Nonsequential Splicing Events Alter Antisense-Mediated Exon Skipping Outcome in COL7A1

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy

(2020) Diane E. Frank et al.   NEUROLOGY

Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse model

(2020) Lei Sheng et al.   NUCLEIC ACIDS RESEARCH

QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study

(2020) Olivier Bornert et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

In Vitro Validation of Phosphorodiamidate Morpholino Oligomers

(2019) May T. Aung-Htut et al.   MOLECULES

Natural exon skipping sets the stage for antisense oligonucleotide-mediated exon skipping as therapy for dystrophic epidermolysis bullosa

(2019) Jeroen Bremer et al.   Molecular Therapy-Nucleic Acids

Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides

(2019) May Aung-Htut et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy

(2016) Jerry R. Mendell et al.   ANNALS OF NEUROLOGY

Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model

(2016) Sandrina Turczynski et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study

(2016) Richard S Finkel et al.   LANCET

Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy

(2016) Olivier Bornert et al.   MOLECULAR THERAPY

GeneBase 1.1: a tool to summarize data from NCBI gene datasets and its application to an update of human gene statistics

(2016) Allison Piovesan et al.   Database-The Journal of Biological Databases and Curation

Antisense Oligonucleotide-mediated Exon Skipping as a Systemic Therapeutic Approach for Recessive Dystrophic Epidermolysis Bullosa

(2016) Jeroen Bremer et al.   Molecular Therapy-Nucleic Acids

ACOL7A1variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa

(2015) A. Schwieger-Briel et al.   BRITISH JOURNAL OF DERMATOLOGY

Identification and Validation of Evolutionarily Conserved Unusually Short Pre-mRNA Introns in the Human Genome

(2015) Makoto Shimada et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Non-sequential and multi-step splicing of the dystrophin transcript

(2015) Isabella Gazzoli et al.   RNA Biology

Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons

(2014) Iris Jonkers et al.   eLife

The Supraspliceosome — A Multi-Task Machine for Regulated Pre-mRNA Processing in the Cell Nucleus

(2014) Kinneret Shefer et al.   Computational and Structural Biotechnology Journal

The MOLGENIS toolkit: rapid prototyping of biosoftware at the push of a button

(2011) Morris A Swertz et al.   BMC BIOINFORMATICS

TheCOL7A1mutation database

(2011) Katarzyna Wertheim-Tysarowska et al.   HUMAN MUTATION

The international dystrophic epidermolysis bullosa patient registry: An online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations

(2011) Peter C. van den Akker et al.   HUMAN MUTATION

Exon 87 skipping of the COL7A1 gene in dominant dystrophic epidermolysis bullosa

(2010) Hiroshi KOGA et al.   JOURNAL OF DERMATOLOGY

A novelde novosplice-site mutation in theCOL7A1gene in dominant dystrophic epidermolysis bullosa (DDEB): specific exon skipping could be a prognostic factor for DDEB pruriginosa

(2009) M. Saito et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Dystrophic Epidermolysis Bullosa: Pathogenesis and Clinical Features

(2009) Leena Bruckner-Tuderman   DERMATOLOGIC CLINICS

Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa

(2008) Ningning Dang et al.   EXPERIMENTAL DERMATOLOGY

PCR-amplification of GC-rich regions: 'slowdown PCR'

(2008) Ulrich H Frey et al.   Nature Protocols